









Märkte
/
Aktien
/
nasdaq-livn
/

LivaNova PLC

LIVN

56.830USD

+2.890+5.36%

Handelsschluss 11/04, 16:00（ET）Kurse um 15 Minuten verzögert

3.10BMarktkapitalisierung

VerlustKGV TTM



LivaNova PLC

56.830

+2.890+5.36%

Übersicht Unternehmen Finanzen Analyse

Übersicht

Unternehmen

Finanzen

Analyse

mehr Informationen über LivaNova PLC Unternehmen

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

LivaNova PLC Informationen



BörsenkürzelLIVN

Name des UnternehmensLivaNova PLC

IPO-datumOct 19, 2015

CEOMr. Vladimir A. Makatsaria

Anzahl der mitarbeiter2900

WertpapierartOrdinary Share

GeschäftsjahresendeOct 19

Addresse20 Eastbourne Terrace

StadtLONDON

BörseNASDAQ Global Select Consolidated

LandUnited Kingdom

PostleitzahlW2 6LG

Telefon442033250662

Websitehttps://www.livanova.com/

BörsenkürzelLIVN

IPO-datumOct 19, 2015

CEOMr. Vladimir A. Makatsaria

Führungskräfte von LivaNova PLC



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

Franco Poletti ,

President, Cardiopulmonary Business Unit

8.52K

+4.49%

Ms. Brooke Story

Independent Director

6.48K

+86.48%

Mr. Michael Damon Hutchinson

Senior Vice President, Chief Legal Officer, Company Secretary

5.67K

Ahmet Tezel

Senior Vice President, Chief Innovation Officer

1.94K

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Keine Daten

Nach RegionUSD

Name

Umsatz

Anteil

United States

188.47M

53.46%

Rest of World

97.27M

27.59%

Europe

66.78M

18.94%

Nach Geschäftsbereich

Nach Region

Keine Daten

Aktionärsstatistik

Aktualisiert: Tue, Aug 19

Aktionäre

Aktionärstypen

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

11.67%

PRIMECAP Management Company

8.50%

The Vanguard Group, Inc.

4.47%

Millennium Management LLC

4.44%

State Street Investment Management (US)

3.81%

Andere

67.10%

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

11.67%

PRIMECAP Management Company

8.50%

The Vanguard Group, Inc.

4.47%

Millennium Management LLC

4.44%

State Street Investment Management (US)

3.81%

Andere

67.10%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

47.30%

Investment Advisor/Hedge Fund

34.79%

Hedge Fund

15.49%

Research Firm

2.72%

Pension Fund

2.17%

Bank and Trust

1.36%

Individual Investor

0.36%

Sovereign Wealth Fund

0.09%

Insurance Company

0.04%

Institutionelle Beteiligung



Aktualisiert: Sun, Oct 5

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

561

56.75M

103.93%

-8.11M

2025Q2

564

56.85M

104.11%

-6.95M

2025Q1

581

56.61M

103.82%

-8.04M

2024Q4

586

56.98M

104.84%

-8.56M

2024Q3

563

55.15M

101.56%

-9.48M

2024Q2

546

57.21M

105.64%

-8.52M

2024Q1

547

58.00M

107.51%

-6.90M

2023Q4

532

56.62M

105.11%

-7.28M

2023Q3

527

56.14M

104.20%

-8.51M

2023Q2

529

55.56M

103.33%

-9.55M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

BlackRock Institutional Trust Company, N.A.

6.37M

11.67%

-150.58K

-2.31%

Jun 30, 2025

PRIMECAP Management Company

4.64M

8.5%

+32.94K

+0.71%

Jun 30, 2025

The Vanguard Group, Inc.

2.44M

4.47%

-214.69K

-8.09%

Jun 30, 2025

Millennium Management LLC

2.43M

4.44%

+360.76K

+17.47%

Jun 30, 2025

State Street Investment Management (US)

2.08M

3.81%

-17.41K

-0.83%

Jun 30, 2025

AQR Capital Management, LLC

2.05M

3.75%

+478.52K

+30.45%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.61M

2.96%

+282.33K

+21.20%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.43M

2.62%

+18.55K

+1.31%

Jun 30, 2025

Wellington Management Company, LLP

1.28M

2.34%

+805.32K

+170.32%

Jun 30, 2025

Artisan Partners Limited Partnership

1.25M

2.29%

+661.48K

+112.86%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Sun, Nov 2

Name

Anteil

SPDR S&P Health Care Equipment ETF

1.52%

JPMorgan Active Small Cap Value ETF

1.19%

Federated Hermes MDT Small Cap Core ETF

0.56%

Invesco NASDAQ Future Gen 200 ETF

0.45%

Global X Aging Population ETF

0.41%

Simplify Health Care ETF

0.4%

iShares US Small Cap Value Factor ETF

0.36%

Avantis US Small Cap Equity ETF

0.33%

iShares U.S. Medical Devices ETF

0.33%

First Trust Active Factor Mid Cap ETF

0.32%

SPDR S&P Health Care Equipment ETF

Anteil1.52%

JPMorgan Active Small Cap Value ETF

Anteil1.19%

Federated Hermes MDT Small Cap Core ETF

Anteil0.56%

Invesco NASDAQ Future Gen 200 ETF

Anteil0.45%

Global X Aging Population ETF

Anteil0.41%

Simplify Health Care ETF

Anteil0.4%

iShares US Small Cap Value Factor ETF

Anteil0.36%

Avantis US Small Cap Equity ETF

Anteil0.33%

iShares U.S. Medical Devices ETF

Anteil0.33%

First Trust Active Factor Mid Cap ETF

Anteil0.32%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

KeyAI

